Pfizer spinoff sues Raleigh biotech over patents

A Pfizer spinoff is suing a Raleigh biotechnology firm and its founder over intellectual property rights.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.